SureTrader
Interactive Brokers Advertisement
Home > Boards > US OTC > Medical - Drugs >

Elite Pharmaceuticals (ELTP)

ELTP RSS Feed
Add ELTP Price Alert      Hide Sticky   Hide Intro
Moderator: Drugdoctor, dr_lowenstein, lasers, NASDAQ2020, IB_, Chasing
Search This Board: 
Last Post: 10/18/2017 10:56:43 AM - Followers: 833 - Board type: Free - Posts Today: 102

Elite Pharmaceuticals, Inc. (ELTP)

 
About Elite Pharmaceuticals
 
Elite Pharmaceuticals is a specialty pharmaceutical company specializing in niche generics and committed to the development of abuse-deterrent opioids to help curb diversion, misuse and abuse.  Elite has a pipeline of opioid abuse-deterrent products under development utilizing the company’s proprietary pharmacological abuse-deterrent technology. 
 
Located in Northvale, New Jersey, Elite operates a 55,000 square foot campus under Current Good Manufacturing Practice (“cGMP”) and is a United States Drug Enforcement Agency (“DEA”) registered facility for research, development, manufacturing and packaging of pharmaceutical products.
 
More information including Elite’s proprietary Abuse Resistant Technology can be found at http://www.elitepharma.com
 


About Elite's Abuse Deterrent Technology

Elite's abuse deterrent products utilize the Company's proprietary pharmacological abuse deterrent technology. Elite's abuse deterrent technology is a multi-particulate capsule which contains an opioid agonist in addition to naltrexone, an opioid antagonist. Naltrexone is an opioid receptor antagonist used primarily in the management of alcohol dependence and opioid dependence. When this product is taken as intended, the naltrexone is designed to pass through the body unreleased while the opioid agonist releases over time providing therapeutic pain relief for which it is prescribed. If the multi-particulate beads are crushed, the opioid antagonist, naltrexone, is designed to release. The absorption of the naltrexone is intended to block the euphoria by preferentially binding to same receptors in the brain as the opioid agonist and thereby reducing the incentive for abuse or misuse by recreational drug abusers.
 
Elite continues to expands the intellectual property for the Company's opioid abuse deterrent technology. Elite now has four US patents, one European patent, and two Canadian patents issued in this area with additional patents pending in the U.S., Canada and Europe.
 
Products & Pipeline
 
Screen%20Shot%202017-05-28%20at%2011.53.29%20AM.png
 
Elite’s principle product is SequestOx, an immediate-release oxycodone with sequestered naltrexone abuse-deterrent opioid product for the management of moderate to severe acute pain. Additional products include bariatric, cardiovascular, antihistamine, skeletal muscle relaxants, antipsychotic, tricyclic antidepressant, along with a number of approved products pending manufacturing site transfer.
 
Elite owns generic and OTC products which have been licensed to TAGI Pharma, Epic Pharma, Dr. Reddy's Laboratories and Valeant Pharmaceuticals International. Additional information regarding Elite’s wholly owned products, partnerships, and contract manufacturing can be found at  http://www.elitepharma.com/products
 
The list of pipeline products can be found at http://www.elitepharma.com/pipeline-generics
 
Leadership
 
Nasrat Hakim, Chairman, President & Chief Executive Officer
 
Nasrat Hakim joined Elite in August 2013 as Director, President and Chief Executive Officer. Mr. Hakim has more than 30 years of pharmaceutical and medical industry experience in Quality Assurance, Analytical Research and Development, Technical Services and Regulatory Compliance. He brings with him proven management experience, in-depth knowledge of manufacturing systems, development knowledge in immediate and extended release formulations and extensive regulatory experience of GMP and FDA regulations. Prior to his leading Elite, from 2004 to 2013, Mr. Hakim was employed by Actavis, Watson and Alpharma in various senior management positions. Most recently, Mr. Hakim served as International Vice President of Quality Assurance at Actavis, overseeing 25 sites with more than 3,000 employees under his leadership.  Mr. Hakim also served as Corporate Vice President of Technical Services, Quality and Regulatory Compliance for Actavis U.S., Global Vice President, Quality and Regulatory Compliance for Alpharma, as well as Executive Director of Quality Unit at TheraTech, overseeing manufacturing and research and development. In 2009, Mr. Hakim founded Mikah Pharma, LLC, a virtual, fully functional pharmaceutical company. 

Mr. Hakim’s career started in Medical Laboratory Technology from the Academy of Health and Sciences in the U.S. Army based in San Antonio, TX, followed by Graduate Certification in Regulatory Affairs (RAC) from California State University at Sacramento, Sacramento, CA; Bachelor in Chemistry/Bio-Chemistry and Masters of Science in Chemistry from California State University at Sacramento, Sacramento, CA; and a Masters in Law with Graduate Certification in U.S. Taxation from St. Thomas University, School of Law, Miami, FL.
 

Investor Relations and Corporate Inquiries

Dianne Will
Vice President of Investor Relations and Corporate Affairs
Telephone: 518-398-6222
Email: 
dianne@elitepharma.com

Corporate Headquarters
165 Ludlow Avenue
Northvale, New Jersey 07647
Phone: 201-750-2646
Fax: 201-750-2755


 

Miscellaneous Links:
 
Elite Pharmaceuticals News
http://ir.elitepharma.com/press_releases
 
SEC Filings
http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001053369&owner=include

FDA website
http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails

Clinical Trials.Gov
https://www.clinicaltrials.gov/
 
Yahoo Finance
https://finance.yahoo.com/quote/ELTP/?p=ELTP
 
Seeking Alpha
https://seekingalpha.com/symbol/ELTP
 

ELTP Daily Chart
    


SureTrader
Interactive Brokers Advertisement
ELTP
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ELTP News: Confidential Treatment Order (ct Order) 10/11/2017 12:26:51 PM
ELTP News: Current Report Filing (8-k) 09/07/2017 04:32:57 PM
ELTP News: Current Report Filing (8-k) 08/09/2017 05:01:18 PM
ELTP News: Quarterly Report (10-q) 08/09/2017 04:30:20 PM
ELTP News: Current Report Filing (8-k) 07/28/2017 12:59:52 PM
PostSubject
#271297  Sticky Note Elite Pharmaceuticals Files ANDA for Oxycodone Hydrochloride Extended Release SCHH 09/20/17 08:41:36 AM
#271038  Sticky Note Elite Pharma at Pain Week 2017 NASDAQ2020 09/17/17 04:03:01 PM
#260714  Sticky Note Uh, no. WeeZuhl 06/13/17 02:21:47 PM
#234937  Sticky Note THIS IS WHAT YOU NEED TO KNOW BEFORE Couch 11/30/16 03:04:07 PM
#189564  Sticky Note $ELTP SequestOx and ADF Patents lasers 03/18/16 04:29:26 AM
#185967  Sticky Note The only topic here is ELTP. IH Dan (Retired) 02/23/16 09:32:46 PM
#274094   Is that after the SHORT VOLUME is provided namtae 10/18/17 11:02:54 AM
#274093   Funny for the last few years all I John_Langston 10/18/17 11:01:55 AM
#274092   Very obvious, cannot be disputed namtae 10/18/17 11:01:33 AM
#274091   95% of traders lose money, another 4% make Couch 10/18/17 10:58:25 AM
#274089   My thought is that ELTP has been a conix 10/18/17 10:56:43 AM
#274088   Gee you mean one has to sign a Couch 10/18/17 10:54:39 AM
#274087   As he needs to............one can start by capping Couch 10/18/17 10:53:23 AM
#274086   LMAO; got it so Elite isn't on a Couch 10/18/17 10:51:30 AM
#274085   Elite is diluting too much and not "closing IB_ 10/18/17 10:42:49 AM
#274084   Look at L2. This will fall fast. John_Langston 10/18/17 10:41:49 AM
#274083   More bad news.. namtae 10/18/17 10:35:04 AM
#274082   Elite is currently bid $0.0852. If it trades namtae 10/18/17 10:26:35 AM
#274081   2017 ADF Formulation UPDATE NASDAQ2020 10/18/17 10:23:22 AM
#274080   Insiders Hoarding massive amounts of shares. NASDAQ2020 10/18/17 10:20:39 AM
#274079   Ouch, another new 52 week low. John_Langston 10/18/17 10:20:21 AM
#274078   I just hope Elite doesnt make a 3rd namtae 10/18/17 10:16:12 AM
#274077   You will have to call Fidelity and sign John_Langston 10/18/17 10:13:39 AM
#274076   Right now Atty General Jeff Sessions will be newguy11 10/18/17 10:12:46 AM
#274075   On a foreign exchange that Lasers was talking about. John_Langston 10/18/17 10:10:23 AM
#274074   Indeed retail is usually the one on the Couch 10/18/17 10:10:09 AM
#274073   Another NEW 52 week low $0.0862 namtae 10/18/17 10:06:46 AM
#274072   $0.0863 ELites NEW 52 week LOW namtae 10/18/17 10:01:21 AM
#274071   I can't do it with scottrade either.. most newguy11 10/18/17 10:00:36 AM
#274070   ***BREAKING NEWS** Elite breaks NEW 52 week LOW, again namtae 10/18/17 09:59:17 AM
#274069   Now tell me where I can do this Couch 10/18/17 09:57:56 AM
#274068   Sort of like 45,000 shares at .108 LMAO!!! namtae 10/18/17 09:54:18 AM
#274067   http://www.investopedia.com/ask/answers/06/otcpinksheetshortselling.asp newguy11 10/18/17 09:54:10 AM
#274066   I see a new 52 week low coming Couch 10/18/17 09:52:03 AM
#274065   LMAO; please tell me how I can short Couch 10/18/17 09:49:48 AM
#274064   I see a new 52 week low coming John_Langston 10/18/17 09:47:28 AM
#274063   Now your going to say market makers can't newguy11 10/18/17 09:45:26 AM
#274062   Its only the 18th and already 1.9 million John_Langston 10/18/17 09:44:57 AM
#274061   Sure would be nice if Ihub could hold namtae 10/18/17 09:43:26 AM
#274060   http://otcshortreport.com/company/ELTP?index=ELTP Its only the 18th and alrea newguy11 10/18/17 09:41:02 AM
#274059   Not everyone is a savvy trader. That's how John_Langston 10/18/17 09:36:31 AM
#274058   Why pay .108 for Elite shares when everyone namtae 10/18/17 09:34:02 AM
#274057   Not a word, I only try to save John_Langston 10/18/17 09:34:02 AM
#274056   PROOF we live in a parallel universe with sharkey1 10/18/17 09:32:49 AM
#274055   LOL, Proof can be given that 45,000 shares John_Langston 10/18/17 09:32:00 AM
#274054   OK but please dont share. The less competition namtae 10/18/17 09:29:34 AM
#274053   PM me Elite's ticker on the Frankfurt Exchange John_Langston 10/18/17 09:28:38 AM
#274052   Both making easy money off Elite by being namtae 10/18/17 09:23:03 AM
#274051   Nice, that's ten times better than my 85,000 John_Langston 10/18/17 09:18:41 AM
#274050   The exchange rate confuses a lot of investors namtae 10/18/17 09:14:06 AM
#274049   Prove Elite doesnt trade on the Frankfurt... Ill wait.. namtae 10/18/17 09:11:12 AM
#274048   Didn't someone just post the huge increase in John_Langston 10/18/17 09:09:00 AM
#274047   Gee and yet not a single shred of Couch 10/18/17 09:02:37 AM
#274046   Nice; you have to love these OTC junk John_Langston 10/18/17 08:58:59 AM
#274045   Best part about Elite on the Frankfurt is namtae 10/18/17 08:54:51 AM
#274044   That's what I said at 57¢. lol John_Langston 10/18/17 08:53:23 AM
PostSubject